Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction

B. Smith; P. Selby; J. Southgate; K. Pittman; C. Bradley; G. E. Blair

doi:10.1016/0140-6736(91)92100-G

Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction

B. Smith, P. Selby^*, J. Southgate, K. Pittman, C. Bradley, G. E. Blair

^*Corresponding author for this work

Jack Birch Unit

Research output: Contribution to journal › Article › peer-review

Abstract

Only small numbers of cells from solid tumours are needed for haematogenous metastasis. Detection is difficult because existing techniques are not sensitive enough. We have used reverse transcriptase to make complementary DNA from peripheral blood messenger RNA, and the polymerase chain reaction (PCR) to amplify cDNA specific for a gene actively transcribed only in the tumour tissue type. We prepared c DNA from peripheral blood of seven patients with malignant melanoma, four patients with other metastatic cancers, and four healthy subjects, as well as from several melanoma-derived cell lines. PCR was used to amplify the gene for tyrosinase, a tissue-specific gene in melanocytes. Since normal melanocytes are not thought to circulate in peripheral blood, detection of tyrosinase transcription in peripheral blood should indicate the presence of circulating cancer cells. The method was highly sensitive and could detect a single melanoma cell from a cell line in 2 ml normal blood. Blood samples from four of the seven patients with malignant melanoma gave positive results, whereas all eight control subjects gave negative results. This method does not depend on the characterisation of cancer-specific genetic abnormalities and can be applied to any cancer for which tissue-specific genes can be identified, including epithelial cancers. It could prove useful in the diagnosis of primary or metastatic cancers, in assessing prognosis, and in detecting residual disease after treatment.

Original language	English
Pages (from-to)	1227-1229
Number of pages	3
Journal	Lancet
Volume	338
Issue number	8777
DOIs	https://doi.org/10.1016/0140-6736(91)92100-G
Publication status	Published - 16 Nov 1991

Access to Document

10.1016/0140-6736(91)92100-G

Cite this

@article{ec032ba1e76a47dcb37f2229b5c2227c,

title = "Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction",

abstract = "Only small numbers of cells from solid tumours are needed for haematogenous metastasis. Detection is difficult because existing techniques are not sensitive enough. We have used reverse transcriptase to make complementary DNA from peripheral blood messenger RNA, and the polymerase chain reaction (PCR) to amplify cDNA specific for a gene actively transcribed only in the tumour tissue type. We prepared c DNA from peripheral blood of seven patients with malignant melanoma, four patients with other metastatic cancers, and four healthy subjects, as well as from several melanoma-derived cell lines. PCR was used to amplify the gene for tyrosinase, a tissue-specific gene in melanocytes. Since normal melanocytes are not thought to circulate in peripheral blood, detection of tyrosinase transcription in peripheral blood should indicate the presence of circulating cancer cells. The method was highly sensitive and could detect a single melanoma cell from a cell line in 2 ml normal blood. Blood samples from four of the seven patients with malignant melanoma gave positive results, whereas all eight control subjects gave negative results. This method does not depend on the characterisation of cancer-specific genetic abnormalities and can be applied to any cancer for which tissue-specific genes can be identified, including epithelial cancers. It could prove useful in the diagnosis of primary or metastatic cancers, in assessing prognosis, and in detecting residual disease after treatment.",

author = "B. Smith and P. Selby and J. Southgate and K. Pittman and C. Bradley and Blair, {G. E.}",

year = "1991",

month = nov,

day = "16",

doi = "10.1016/0140-6736(91)92100-G",

language = "English",

volume = "338",

pages = "1227--1229",

journal = "Lancet",

issn = "0140-6736",

publisher = "Elsevier",

number = "8777",

}

TY - JOUR

T1 - Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction

AU - Smith, B.

AU - Selby, P.

AU - Southgate, J.

AU - Pittman, K.

AU - Bradley, C.

AU - Blair, G. E.

PY - 1991/11/16

Y1 - 1991/11/16

N2 - Only small numbers of cells from solid tumours are needed for haematogenous metastasis. Detection is difficult because existing techniques are not sensitive enough. We have used reverse transcriptase to make complementary DNA from peripheral blood messenger RNA, and the polymerase chain reaction (PCR) to amplify cDNA specific for a gene actively transcribed only in the tumour tissue type. We prepared c DNA from peripheral blood of seven patients with malignant melanoma, four patients with other metastatic cancers, and four healthy subjects, as well as from several melanoma-derived cell lines. PCR was used to amplify the gene for tyrosinase, a tissue-specific gene in melanocytes. Since normal melanocytes are not thought to circulate in peripheral blood, detection of tyrosinase transcription in peripheral blood should indicate the presence of circulating cancer cells. The method was highly sensitive and could detect a single melanoma cell from a cell line in 2 ml normal blood. Blood samples from four of the seven patients with malignant melanoma gave positive results, whereas all eight control subjects gave negative results. This method does not depend on the characterisation of cancer-specific genetic abnormalities and can be applied to any cancer for which tissue-specific genes can be identified, including epithelial cancers. It could prove useful in the diagnosis of primary or metastatic cancers, in assessing prognosis, and in detecting residual disease after treatment.

AB - Only small numbers of cells from solid tumours are needed for haematogenous metastasis. Detection is difficult because existing techniques are not sensitive enough. We have used reverse transcriptase to make complementary DNA from peripheral blood messenger RNA, and the polymerase chain reaction (PCR) to amplify cDNA specific for a gene actively transcribed only in the tumour tissue type. We prepared c DNA from peripheral blood of seven patients with malignant melanoma, four patients with other metastatic cancers, and four healthy subjects, as well as from several melanoma-derived cell lines. PCR was used to amplify the gene for tyrosinase, a tissue-specific gene in melanocytes. Since normal melanocytes are not thought to circulate in peripheral blood, detection of tyrosinase transcription in peripheral blood should indicate the presence of circulating cancer cells. The method was highly sensitive and could detect a single melanoma cell from a cell line in 2 ml normal blood. Blood samples from four of the seven patients with malignant melanoma gave positive results, whereas all eight control subjects gave negative results. This method does not depend on the characterisation of cancer-specific genetic abnormalities and can be applied to any cancer for which tissue-specific genes can be identified, including epithelial cancers. It could prove useful in the diagnosis of primary or metastatic cancers, in assessing prognosis, and in detecting residual disease after treatment.

UR - http://www.scopus.com/inward/record.url?scp=0026042387&partnerID=8YFLogxK

U2 - 10.1016/0140-6736(91)92100-G

DO - 10.1016/0140-6736(91)92100-G

M3 - Article

C2 - 1719320

AN - SCOPUS:0026042387

SN - 0140-6736

VL - 338

SP - 1227

EP - 1229

JO - Lancet

JF - Lancet

IS - 8777

ER -

Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction

Abstract

Access to Document

Other files and links

Cite this